“This is due to Intel,” said Chief Scientific Officer Sergey Dryga, who said the computer chip company’s semiconductor technologies have commonalities with what BioDirection is developing. The capabilities of local universities also played a role, he said.
BioDirection’s Tbit System is designed to detect and measure biomarkers released in the…
Source: The Business Journal